ahlam1399
05-28-2015, 09:24 PM
Otsuka loses lawsuit challenging FDA approval of generic Abilify
(Reuters) - Otsuka Pharmaceutical Co Ltd has lost a lawsuit challenging the U.S. Food and Drug Administration's decision to allow generic versions of the company's antipsychotic drug Abilify.http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/46bac716/sc/7/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=4Yjd3dI9a3U:Ke31Ghh1rr4:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=4Yjd3dI9a3U:Ke31Ghh1rr4:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=4Yjd3dI9a3U:Ke31Ghh1rr4:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=4Yjd3dI9a3U:Ke31Ghh1rr4:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=4Yjd3dI9a3U:Ke31Ghh1rr4:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/4Yjd3dI9a3U
(Reuters) - Otsuka Pharmaceutical Co Ltd has lost a lawsuit challenging the U.S. Food and Drug Administration's decision to allow generic versions of the company's antipsychotic drug Abilify.http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/46bac716/sc/7/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=4Yjd3dI9a3U:Ke31Ghh1rr4:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=4Yjd3dI9a3U:Ke31Ghh1rr4:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=4Yjd3dI9a3U:Ke31Ghh1rr4:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=4Yjd3dI9a3U:Ke31Ghh1rr4:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=4Yjd3dI9a3U:Ke31Ghh1rr4:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/4Yjd3dI9a3U